Currently, there are 57.82M common shares owned by the public and among those 54.45M shares have been available to trade.
The company’s stock has a 5-day price change of 0.19% and 22.89% over the past three months. EOLS shares are trading 50.90% year to date (YTD), with the 12-month market performance up to 58.58% higher. It has a 12-month low price of $7.44 and touched a high of $16.29 over the same period. EOLS has an average intraday trading volume of 511.98K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 10.71%, 25.20%, and 29.92% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Evolus Inc (NASDAQ: EOLS) shares accounts for 81.84% of the company’s 57.82M shares outstanding.
It has a market capitalization of $1.00B and a beta (3y monthly) value of 1.30. The earnings-per-share (ttm) stands at -$0.91. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.47% over the week and 3.88% over the month.
Analysts forecast that Evolus Inc (EOLS) will achieve an EPS of -0.09 for the current quarter, -0.01 for the next quarter and 0.16 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.13 while analysts give the company a high EPS estimate of -0.13. Comparatively, EPS for the current quarter was -0.16 a year ago. Earnings per share for the fiscal year are expected to increase by 46.44%, and 118.50% over the next financial year. EPS should grow at an annualized rate of 16.50% over the next five years, compared to 10.81% over the past 5-year period.
Looking at the support for the EOLS, a number of firms have released research notes about the stock. Barclays stated their Overweight rating for the stock in a research note on January 29, 2024, with the firm’s price target at $10-$16. Needham coverage for the Evolus Inc (EOLS) stock in a research note released on June 23, 2022 offered a Buy rating with a price target of $18. Barclays was of a view on May 12, 2022 that the stock is Equal Weight, while Truist gave the stock Buy rating on January 20, 2022, issuing a price target of $11. Mizuho on their part issued Buy rating on May 06, 2021.
